[High doses of calcium carbonate or the combination of 1 alpha hydroxylated derivatives of vitamin D and aluminum compounds bound to phosphorus in the preventive treatment of renal osteodystrophy].
Fournier
A
A
Service de Néphrologie, CHU, Amiens.
Morinière
P
P
Boudailliez
B
B
Marie
A
A
Westeel
P F
PF
Renaud
M
M
Belbrik
S
S
Hocine
C
C
Sebert
J L
JL
D000534:Alum Compounds / Q000627:therapeutic use*; D000535:Aluminum / Q000627:therapeutic use*; D002119:Calcium Carbonate / Q000008:administration & dosage / Q000627:therapeutic use*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D010018:Osteomalacia / Q000503:physiopathology; D010758:Phosphorus / Q000627:therapeutic use; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000534:Alum Compounds; C005479:magnesium carbonate; D014807:Vitamin D; D010758:Phosphorus; D000535:Aluminum; D002119:Calcium Carbonate; D008274:Magnesium
Le carbonate de calcium à fortes doses ou l'association dérivés 1 alpha hydroxylés de la vitamine D et complexants aluminiques du phosphore dans le traitement préventif de l'ostéodystrophie rénale.